Event Details

22nd EURETINA Congress, Euretina Session 8: Late Breakings

Sep 2, 2022 at 7:45 AM PDT

Title: KSI-301 Anti-VEGF Antibody Biopolymer Conjugate for Retinal Vein Occlusion: Primary 24-Week Efficacy and Safety Outcomes of the BEACON Phase 3 Pivotal Study
Presenter: Arshad Khanani, M.D., M.A., FASRS, Director of Clinical Research, Sierra Eye Associates, Reno, NV

Supporting Materials


Hamburg, Germany